Brief: Nightingale Health Acquires Negen, Launches International Centre Of Excellence For Genomic Data Analysis

Nightingale Health Oyj

18/01/2022 07:34

Jan 18 (Reuters) - Nightingale Health Oyj  HEALTH.HE :
    * ACQUIRES FINNISH GENETIC TESTING COMPANY NEGEN AND
LAUNCHES
INTERNATIONAL CENTRE OF EXCELLENCE FOR GENOMIC DATA ANALYSIS
    * TRANSACTION IS ESTIMATED TO HAVE POSITIVE IMPACT ON
NIGHTINGALE'S REVENUE IN LONG TERM
    * AGREED PURCHASE PRICE IS PAID IN CASH AND IT IS NOT
SIGNIFICANT
IN TERMS OF NIGHTINGALE'S CASH POSITION
    * TRANSACTION IS EXPECTED TO BE COMPLETED, SUBJECT TO
FULFILMENT
OF CONDITIONS PRECEDENT, DURING JANUARY 2022
    * NEGEN'S REVENUE PRIOR TO TRANSACTION HAS BEEN AROUND
50,000-150,000 EUROS ANNUALLY
    * FIRST PRODUCTS INTEGRATING NIGHTINGALE'S PROPRIETARY BLOOD
TEST
AND GENOMIC DATA WILL LAUNCH IN SECOND HALF OF 2022

Source text for Eikon:  ID:nWkr3NR5Nn 
Further company coverage:  HEALTH.HE 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;;))